Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits.
about
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinolNative LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situThe vascular endothelium and human diseasesRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisEndothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitrationChlorine gas exposure causes systemic endothelial dysfunction by inhibiting endothelial nitric oxide synthase-dependent signalingOxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signalingNitric oxide is a physiological substrate for mammalian peroxidasesXanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.Protection against peroxynitrite.Oxidative risk for atherothrombotic cardiovascular disease.Role for NADPH/NADH oxidase in the modulation of vascular tone.Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung.Modulation of vascular endothelial function by low-density lipoprotein cholesterol with aging: influence of habitual exercise.Coronary microvascular dysfunction in diabetes mellitus: A reviewProtective effect of arginine on oxidative stress in transgenic sickle mouse models.The impairment of endothelium-dependent arterial relaxation by 7-ketocholesterol is associated with an early activation of protein kinase CInfluence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.Xanthine Oxidoreductase Function Contributes to Normal Wound HealingMicrovascular responsiveness in obesity: implications for therapeutic intervention.Uric acid as a pathogenic factor in preeclampsia.Reactive oxygen species-mediated signal transduction in the endothelium.Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemiaEndothelial dysfunction in obstructive sleep apnea.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.Reactive oxygen species: toxic molecules or spark of life?Assessment of old and new proteins: a novel methodology.Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal.The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.Atherosclerosis and the Hypercholesterolemic AGE-RAGE AxisRole of TNF-alpha in vascular dysfunction.Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbitsWater-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis.Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation.Free radical generation by methylglyoxal in tissues.Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.The role of inflammatory cytokines in endothelial dysfunction
P2860
Q24652967-056E6E94-555A-4708-9F62-816B9773A224Q28215041-76F7B991-6218-46CE-8609-C6ABA90996FAQ28302238-F50DD7F4-9D61-4222-B32E-5169F328AA38Q28354735-C2395AD6-D639-451E-BFB7-8E7B1CF4105CQ28366645-24B99A87-7A2B-4392-8E29-6520BE7E3C94Q28392042-2996EE22-07C3-4EA1-84F0-A08CA9FC5EA1Q28393242-903AF27A-7007-4B00-9C40-D3BEBD788398Q28645799-28922529-B75E-4DFC-9160-3DB79776C99EQ30336517-AD9FEFE7-5551-4268-938E-11D7B9FB8003Q33365148-F90C5F6B-9C84-43A3-8FBF-53E98C7E070DQ33545657-FB84E3C9-E023-4720-BD8B-2C6903A7933CQ33554184-DFB6FE96-30C0-41AA-AF53-7977BDF8A50FQ33692492-9A3D0897-4832-41B4-8E4E-E64F89B58037Q33953052-84F73E11-B779-456E-8E20-92CE53BC1966Q34053084-4D580692-9F83-4F67-8CA9-6D30772926FCQ34064636-B835DA65-78D2-452E-B084-317A0B28F0BCQ34427072-B68FE62E-4EEE-4FDD-A2FA-8F17CBEE30F8Q34589136-2979FB2E-D6C3-4A6F-ABA2-0B73008D1475Q35044693-6BF2BE96-55B1-4E1F-B29C-6605C7CDC9F6Q35613484-70192489-3C1E-43E7-86FA-25357ADA0166Q35855645-E801827D-D557-4F6C-AC36-453A5740D584Q35859728-62B8E803-5D76-4EC1-83E9-998B8F6F6CB9Q35868968-26AEE39E-772A-415E-90A8-49793FE744F5Q35888592-C34A7ECE-76E0-44A4-8A65-F79E0048F665Q35989704-ED97ACD4-33D7-46E6-8CC5-655EB0158E66Q35995356-EFE59C10-D943-48C3-B2CE-CF2EA8FC97C3Q36065338-09006B6E-2F51-49F1-A0CD-4F3D83338809Q36319955-147D2A9E-C491-4820-BD26-80BEC4CDE2BAQ36392238-7EF1D989-CD71-4F5A-B7A8-A66609E341E3Q36511103-E6905B97-96E2-4330-9274-B278580B4E9EQ36666934-50A8D946-17CE-4D0A-A9C7-65BD29817FFAQ36846068-3500F50D-84BB-4F9A-BC45-9F49209A6F2AQ36909193-FC681464-1DF0-4F0D-9595-F17964826F8AQ37050343-6FCFE527-622C-4982-B1CD-61153D356F1CQ37071609-737E6D55-8E3F-4594-AA92-00389DE80898Q37102203-11142C4C-7A17-4894-90D0-0ADAB1A8FEDAQ37133541-CAD78179-2ADE-440C-B885-B01857070805Q37183298-597A33A3-E115-425E-BF5B-29F28ADFBCD9Q37190915-1CE716BA-C9FB-43E3-81E3-D39D52173E22Q37207043-0ED79896-61F2-4039-A3EB-8A3B993B99EB
P2860
Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@en
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@nl
type
label
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@en
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@nl
prefLabel
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@en
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@nl
P2093
P2860
P356
P1476
Circulating plasma xanthine ox ...... hypercholesterolemic rabbits.
@en
P2093
B A Freeman
J A Thompson
M M Tarpey
V Darley-Usmar
W R Berrington
P2860
P304
P356
10.1073/PNAS.93.16.8745
P407
P577
1996-08-01T00:00:00Z